<?xml version="1.0" encoding="UTF-8"?>
<p id="Par3">According to The Joint United Nations Programme on HIV and AIDS (UNAIDS) and the World Health Organization (WHO), a 6-month disruption of antiretroviral therapy (ART) during the COVID-19 pandemic in sub-Saharan Africa will increase HIV-related death rate by more than half a million [
 <xref ref-type="bibr" rid="CR8">8</xref>]. This is corroborated by five well-described models of HIV epidemics which estimated that a 6-month interruption of supply of ART across the whole population of people living with HIV (PLWH) on treatment would be expected to lead to an approximately twofold (from 1.87- to 2.80-fold across models) increase in HIV-related deaths over a 1 year period compared to the case with no disruption [
 <xref ref-type="bibr" rid="CR9">9</xref>]. Given the recent total lockdown in Rwanda, this note presents findings from a study aimed to assess attendance to ART collection clinic appointments in the period 21 March to 30 April 2020 in Kigali, Rwanda.
</p>
